Raptiva suspended in Europe over safety concerns

February 20, 2009
Research and Development, Sales and Marketing Europe, Rapitva

Psoriasis treatment Raptiva is to be suspended from use in the European Union because of concerns about rare but serious …

Servier claims victory over NICE in osteoporosis

February 19, 2009
Research and Development, Sales and Marketing NICE, Servier

Servier has claimed victory in the first round of its legal battle against NICE's guidelines on osteoporosis.A judicial review requested …

GSK’s diabetes candidate enters phase III

February 19, 2009
Research and Development GSK, diabetes

A large scale study of GlaxoSmithKline's type II diabetes candidate Syncria (albiglutide) has begun.Albiglutide is an investigational biological drug, and …

Anger over private firm’s role in prescribing controls

February 19, 2009
NHS

Pharmacy and GP representatives have attacked plans for a private company to oversee primary care prescribing costs.Private provider Assura is …

Sanofi-Aventis joins YouTube revolution

February 18, 2009
Sales and Marketing Sanofi-Aventis, diabetes

Sanofi-Aventis has launched its first YouTube channel, aimed at diabetes sufferers in the US.Reached by typing the keyword goinsulin into …

Genzyme says new plant approval is imminent

February 18, 2009
Research and Development, Sales and Marketing Genzyme

Genzyme has said it expects to get approval to make a Pompe disease treatment at a new US manufacturing unit …

Novartis and charity team up on AMD campaign

February 18, 2009
Medical Communications, Sales and Marketing AMD, ophthalmology

Novartis has teamed up with blindness charity the RNIB on a new campaign to promote awareness of age-related macular degeneration …

Lilly to boost biotech stake in NeuroSearch deal

February 17, 2009
Research and Development Denmark, Europe, NeuroSearch

Lilly has signed a new deal with Danish biotech company NeuroSearch and increased its presence further in the biologics sector.The …

Pharma needs fresh ideas from outside industry, says Barker

February 17, 2009
Research and Development, Sales and Marketing ABPI, strategy

Pharma must re-invent itself and inject new ideas into its business model by hiring talented people from outside the sector, …

Positive results halt Avastin-Tarceva trial

February 16, 2009
Sales and Marketing Cancer, Roche, avastin

A phase III trial has been stopped early after promising results for Avastin and Tarceva combined as first-line maintenance treatment …

GSK: renewing the HIV pipeline

February 16, 2009
Research and Development GSK, HIV

GlaxoSmithKline and Idenix are to co-develop IDX899 for the treatment of HIV infection. Despite having eight marketed HIV products, GSK …

Managers need training too

February 13, 2009
Business Services management, recruitment, training

Most of us recognise that personal training and development is an essential requirement for successful career advancement, but for many …

Working Life: Kay Spiller

February 13, 2009
Sales and Marketing Astellas Pharma Europe, marketing

How did you find your way into your role? This was really through what I would describe as the 'traditional' …

Bayer’s cardiovascular drug enters phase III

February 13, 2009
Research and Development, Sales and Marketing Bayer, cv

Bayer Schering Pharma has begun phase III trials of riociguat for treatment of two life-threatening conditions. Two trials will investigate …

Patient surveys to be a world first for NHS

February 13, 2009
Sales and Marketing NHS, PROMs, hc

Patients who have a hip replacements or varicose vein surgery on the NHS will be among the first patients to …

Viehbacher sets out vision for diversified Sanofi-Aventis

February 11, 2009
Sales and Marketing Sanofi

Sanofi-Aventis's new chief executive Chris Viehbacher has presented his vision to renew the company, which will include greater investment in …

Sanofi cleared to buy Zentiva

February 11, 2009
Sales and Marketing Sanofi, generics

The European Commission says Sanofi-Aventis can go ahead with its planned acquisition of Czech generics company Zentiva. The Commission had …

Novartis boasts strong sales for 2008

February 11, 2009
Sales and Marketing Novartis

Novartis has weathered the financial downturn and delivered a strong performance for 2008. Overall group sales were boosted by 9% …

Health secretary to chair influential pharma group

February 11, 2009
Sales and Marketing ABPI, reform

Health Secretary Alan Johnson has been appointed the chair of the Ministerial Industry Strategy Group (MISG) and business secretary Lord …

Industry braced for more mergers

February 11, 2009
Sales and Marketing MA, restructure

In retrospect, Pfizer's move to buy another major pharmaceutical company was inevitable. Like its peers, Pfizer has been energetically restructuring …

The Gateway to Local Adoption Series

Latest content